Relmada Therapeutics
$35.569876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$35.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.17 (-0.48%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell RLMD and other stocks, options, and ETFs commission-free!
About RLMD
Relmada Therapeutics, Inc. Common Stock, also called Relmada Therapeutics, is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders. The company was founded on May 31, 2012 and is headquartered in New York, NY. The listed name for RLMD is Relmada Therapeutics, Inc. Common Stock.
CEO
Sergio Traversa
Employees
4
Headquarters
New York, New York
Founded
2012
Market Cap
591.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
76.30K
High Today
$36.02
Low Today
$34.90
Open Price
$36.02
Volume
41.23K
52 Week High
$54.00
52 Week Low
$23.25
Collections
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
RLMD Earnings
-$1.05
-$0.70
-$0.35
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, After Hours